iSpecimen
ISPC
10 hedge funds and large institutions have $239K invested in iSpecimen in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
17% less funds holding
Funds holding: 12 → 10 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
60% less capital invested
Capital invested by funds: $597K → $239K (-$358K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$24.7K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$18.5K |
| 3 |
HF
HRT Financial
New York
|
+$15K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$33.1K |
| 2 |
CA
Claro Advisors
Boston,
Massachusetts
|
-$24.7K |
| 3 |
Renaissance Technologies
New York
|
-$21K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$14.1K |
| 5 |
Morgan Stanley
New York
|
-$11.4K |
ISPC Hedge Fund Activity: Q3 2023 in Review
10 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q3 2023, worth a combined $239K — down 60% from $597K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ISPC and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $24.7K. The largest seller was Citadel Advisors, exiting entirely with an estimated $33.1K sold.
- 10 institutional investors held iSpecimen (ISPC) as of Q3 2023, down from 12 in Q2 2023.
- Funds reported $239K of iSpecimen stock for Q3 2023, down 60% quarter-over-quarter.
- 2 funds opened new iSpecimen positions in Q3 2023 and 4 closed out, a net change of -2 holders.
- The largest iSpecimen buyer in Q3 2023 was Susquehanna International Group, an estimated $24.7K added.
- The largest iSpecimen seller in Q3 2023 was Citadel Advisors, an estimated $33.1K sold.
Based on aggregated 13F filings for Q3 2023.